Earnings & Reporting

Following a major acquisition and the final Worldpay sale, the fintech giant’s upcoming presentation is a key event for investors watching its next move.

With $128.7M in cash and zero debt, Singapore's OMS Energy is leveraging its financial might and a key Saudi Aramco deal to dominate the oilfield market.

Investor bidding across property types has converged to its narrowest spread in three years, signaling a more normalized and stable market for 2026.

Sun Cruiser is now the official cocktail of the U.S. Open. This landmark deal signals a major shift in sports sponsorship and Boston Beer's big bet beyond beer.

The industrial giant earns top global ESG ratings for the third straight year, proving that strategic sustainability drives both environmental impact and investor value.

The telehealth giant is launching a new vertical for healthy aging, aiming to fix a market that has historically ignored women's specific biological needs.

Easterly Asset Management's deal to absorb Olstein's funds marks a key industry consolidation, promising lower fees and a unified value investing powerhouse.

With a network reaching 1.2M providers, ConnectiveRx is embedding pharma messaging into clinical workflows. Is it the future of patient care or a new frontier of commercial influence?

Employer confidence is back to 2022 levels, but a new survey reveals AI's uneven impact and hiring plans were made before new geopolitical tensions.

As Abundia heads to a key investor conference, it's betting on proven tech and a Gulf Coast hub to transform plastic waste into a profitable energy source.

ADP's preliminary data suggested steady hiring, but official government figures show a surprising job loss, fueling debate on US economic health.

For the 12th straight year, Taiwan's E.SUN is in the S&P Sustainability Yearbook, ranking in the top 1% of banks and setting a new global standard.

With its finances on a knife's edge, Faraday Future is pitching a bold new vision of AI robots and mass-market EVs to skeptical investors. Can it deliver?

A large-scale analysis reveals that tenapanor, known as IBSRELA, provides quicker relief from constipation and abdominal pain for adults with IBS-C.

Despite lower revenue, the railcar maker expanded margins and cash flow in 2025, signaling a resilient strategy focused on diversification for 2026.

Nu Skin appoints its top lawyer, Chayce Clark, as COO, a strategic move to drive growth with its new Prysm iO platform and India market expansion.

TelkomGroup sells its healthcare unit to focus on core digital business, as Fullerton Health expands its major presence in Indonesia's TPA market.

Despite a $17.7M Q4 loss, the REIT is overhauling its balance sheet and betting its future on a strategic shift to the booming multifamily market.

Security firm Evolv hits a massive milestone with its AI scanners, but its rapid growth and bold claims spark debate on privacy and market disruption.

Rochester's Syntec Optics lands $4M in key defense orders, cementing its role in supplying advanced optics for missile guidance, night vision, and AI-powered AR.